AU3475189A - Dry compositions for controlled release dosage forms - Google Patents

Dry compositions for controlled release dosage forms

Info

Publication number
AU3475189A
AU3475189A AU34751/89A AU3475189A AU3475189A AU 3475189 A AU3475189 A AU 3475189A AU 34751/89 A AU34751/89 A AU 34751/89A AU 3475189 A AU3475189 A AU 3475189A AU 3475189 A AU3475189 A AU 3475189A
Authority
AU
Australia
Prior art keywords
dosage forms
controlled release
release dosage
dry compositions
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU34751/89A
Inventor
Choong-Gook Jang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU3475189A publication Critical patent/AU3475189A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU34751/89A 1983-05-31 1989-05-15 Dry compositions for controlled release dosage forms Abandoned AU3475189A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US49922183A 1983-05-31 1983-05-31
US499221 1983-05-31
US60047284A 1984-04-16 1984-04-16
US600472 1984-04-16

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
AU29676/84A Division AU581177B2 (en) 1983-05-31 1984-05-29 Dry direct compression compositions for controlled release dosage forms

Publications (1)

Publication Number Publication Date
AU3475189A true AU3475189A (en) 1989-09-07

Family

ID=27053077

Family Applications (2)

Application Number Title Priority Date Filing Date
AU29676/84A Ceased AU581177B2 (en) 1983-05-31 1984-05-29 Dry direct compression compositions for controlled release dosage forms
AU34751/89A Abandoned AU3475189A (en) 1983-05-31 1989-05-15 Dry compositions for controlled release dosage forms

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AU29676/84A Ceased AU581177B2 (en) 1983-05-31 1984-05-29 Dry direct compression compositions for controlled release dosage forms

Country Status (5)

Country Link
EP (1) EP0147437A4 (en)
JP (1) JPH0759502B2 (en)
AU (2) AU581177B2 (en)
BR (1) BR8406921A (en)
WO (1) WO1984004674A1 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3524003A1 (en) 1985-07-04 1987-01-08 Heumann Ludwig & Co Gmbh MEDICINE GRANULES WITH DELAYED ACTIVE SUBSTANCE RELEASE AND METHOD FOR THE PRODUCTION THEREOF
SE455836B (en) * 1985-10-11 1988-08-15 Haessle Ab PREPARATION WITH CONTROLLED RELEASE CONTAINING A SALT OF METOPROLOL AND METHOD FOR PREPARING THIS PREPARATION
US4892742A (en) * 1985-11-18 1990-01-09 Hoffmann-La Roche Inc. Controlled release compositions with zero order release
US4983399A (en) * 1989-10-18 1991-01-08 Eastman Kodak Company Direct compression carrier composition
US5385887A (en) * 1993-09-10 1995-01-31 Genetics Institute, Inc. Formulations for delivery of osteogenic proteins
US5458888A (en) * 1994-03-02 1995-10-17 Andrx Pharmaceuticals, Inc. Controlled release tablet formulation
US7658938B2 (en) 1999-02-22 2010-02-09 Merrion Reasearch III Limited Solid oral dosage form containing an enhancer
WO2002092616A1 (en) 2001-05-11 2002-11-21 Orasense, Ltd. Antisense permeation enhancers
US20030012820A1 (en) * 2001-06-12 2003-01-16 Upadhyay Ajay Hasmukhlal Compressible guaifenesin compositions, method for making same and method for making compressed guaifenesin dosage forms therefrom
EP2007397B1 (en) 2006-04-07 2013-07-24 Merrion Research III Limited Solid oral dosage form containing an enhancer
US8999383B2 (en) 2008-05-07 2015-04-07 Merrion Research Iii Limited Compositions of GnRH related compounds and processes of preparation
US9089484B2 (en) 2010-03-26 2015-07-28 Merrion Research Iii Limited Pharmaceutical compositions of selective factor Xa inhibitors for oral administration
KR20140026354A (en) 2011-01-07 2014-03-05 메리온 리서치 Ⅲ 리미티드 Pharmaceutical compositions of iron for oral administration
US10722458B2 (en) * 2011-12-02 2020-07-28 Pegasus Laboratories, Inc. Amphipathic lipid-based sustained release compositions
JP7211704B2 (en) 2015-01-29 2023-01-24 ノヴォ ノルディスク アー／エス A tablet containing a GLP-1 agonist and an enteric coating
US20170114189A1 (en) * 2015-10-27 2017-04-27 Tenstech Inc. Cellulosic microsheets

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE564759A (en) * 1955-12-22
US3402240A (en) * 1957-06-25 1968-09-17 Pfizer & Co C Medicinal tablet and process of making same
US3096248A (en) * 1959-04-06 1963-07-02 Rexall Drug & Chemical Company Method of making an encapsulated tablet
US3062720A (en) * 1959-05-20 1962-11-06 Philips Roxane Sustained release pharmaceutical tablet
US3108046A (en) * 1960-11-25 1963-10-22 Smith Kline French Lab Method of preparing high dosage sustained release tablet and product of this method
US3115441A (en) * 1962-06-06 1963-12-24 Victor M Hermelin Timed release pharmaceutical preparations and method of making the same
US3279998A (en) * 1962-06-22 1966-10-18 Smith Kline French Lab Method of preparing sustained release tablets
NL297357A (en) * 1962-08-31
US3147187A (en) * 1962-09-10 1964-09-01 Don Hall Lab Sustained release pharmaceutical
US3336200A (en) * 1963-05-28 1967-08-15 Warner Lambert Pharmaceutical Tablet structure
NL297631A (en) * 1963-06-03
US3362880A (en) * 1963-09-20 1968-01-09 Dow Chemical Co Compressed drug tablets of ethyl cellulose, glyceryl monostearate, karaya gum, tragacanth, talc, and magnesium stearate
US3400197A (en) * 1965-01-26 1968-09-03 Robins Co Inc A H Compressible sustained release pharmaceutical tablet lipid-colloidal silica gel matrix fragment granules
US3577514A (en) * 1968-06-10 1971-05-04 Pfizer Sustained release pharmaceutical tablets
DE2050701C3 (en) * 1969-10-17 1979-12-20 Shinetsu Chemical Co., Tokio Use of a pulverulent cellulose ether as an adjuvant for the production of easily disintegratable solid pharmaceutical forms
FR2183546B1 (en) * 1972-05-10 1975-06-20 Servier Lab
US3965256A (en) * 1972-05-16 1976-06-22 Synergistics Slow release pharmaceutical compositions
US4167558A (en) * 1976-02-13 1979-09-11 Hoffmann-La Roche Inc. Novel sustained release tablet formulations
AU1873783A (en) * 1982-10-08 1984-04-12 Verex Laboratories Inc. Constant release formulation
US4797288A (en) * 1984-10-05 1989-01-10 Warner-Lambert Company Novel drug delivery system

Also Published As

Publication number Publication date
EP0147437A1 (en) 1985-07-10
WO1984004674A1 (en) 1984-12-06
EP0147437A4 (en) 1987-03-05
BR8406921A (en) 1985-06-04
JPS60501459A (en) 1985-09-05
JPH0759502B2 (en) 1995-06-28
AU2967684A (en) 1984-12-18
AU581177B2 (en) 1989-02-16

Similar Documents

Publication Publication Date Title
AU556588B2 (en) Extended action controlled release composition
AU561144B2 (en) Foam composition for dentistry
AU571560B2 (en) Organosilicone release composition
AU551827B2 (en) Photopolymerisable compositions
AU1873783A (en) Constant release formulation
AU546249B2 (en) Slow release tablet formulation
AU1787583A (en) Polyester-carbonate composition
AU1950483A (en) Dry solid microbiocidal compositions
GB2122490B (en) Controlled release formulation
AU3475189A (en) Dry compositions for controlled release dosage forms
AU1147783A (en) Rtv-organdpolysiloxane composition
GB2141023B (en) Delayed release formulations
AU556090B2 (en) Controlled release formulations
AU1756283A (en) Veterinary composition
AU543848B2 (en) Setting composition for dental purposes
AU1483283A (en) Deoxyuridine compounds
AU569837B2 (en) Polyester-carbonate composition
AU1950383A (en) Particulate microbiocidal compositions
AU551415B2 (en) Sweetener compositions
AU1810583A (en) Slow release indomethacin formulations
AU1459183A (en) Anti-ulcer pharmaceutical composition
AU2796884A (en) Composition for rectal administration
AU556553B2 (en) Composition
GB8405085D0 (en) Controlled release formulation
AU2081583A (en) Oral compositions